147 related articles for article (PubMed ID: 38720348)
1. Characterization of zinc finger protein 536, a neuroendocrine regulator, using pan-cancer analysis.
Zeng L; Zhang L; Yin C; Chen X; Chen X; Sun L; Sun J
Eur J Med Res; 2024 May; 29(1):273. PubMed ID: 38720348
[TBL] [Abstract][Full Text] [Related]
2. P3H4 Overexpression Serves as a Prognostic Factor in Lung Adenocarcinoma.
Jin X; Zhou H; Song J; Cui H; Luo Y; Jiang H
Comput Math Methods Med; 2021; 2021():9971353. PubMed ID: 34257701
[TBL] [Abstract][Full Text] [Related]
3. Identification and validation of tumor environment phenotypes in lung adenocarcinoma by integrative genome-scale analysis.
Bi G; Chen Z; Yang X; Liang J; Hu Z; Bian Y; Sui Q; Li R; Zhan C; Fan H
Cancer Immunol Immunother; 2020 Jul; 69(7):1293-1305. PubMed ID: 32189030
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
[TBL] [Abstract][Full Text] [Related]
5. Signatures of Multi-Omics Reveal Distinct Tumor Immune Microenvironment Contributing to Immunotherapy in Lung Adenocarcinoma.
Huang Z; Li B; Guo Y; Wu L; Kou F; Yang L
Front Immunol; 2021; 12():723172. PubMed ID: 34539658
[TBL] [Abstract][Full Text] [Related]
6. Elevated Expression of
Hu P; Huang Y; Gao Y; Yan H; Li X; Zhang J; Wang Y; Zhao Y
DNA Cell Biol; 2020 Apr; 39(4):522-532. PubMed ID: 32040344
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel therapeutic candidate, NRK, in primary cancer-associated fibroblasts of lung adenocarcinoma microenvironment.
Wei T; Song J; Liang K; Li L; Mo X; Huang Z; Chen G; Mao N; Yang J
J Cancer Res Clin Oncol; 2021 Apr; 147(4):1049-1064. PubMed ID: 33387038
[TBL] [Abstract][Full Text] [Related]
8. Development and Validation of a DNA Methylation-related Classifier of Circulating Tumour Cells to Predict Prognosis and to provide a therapeutic strategy in Lung Adenocarcinoma.
Gu X; Huang X; Zhang X; Wang C
Int J Biol Sci; 2022; 18(13):4984-5000. PubMed ID: 35982906
[No Abstract] [Full Text] [Related]
9. Comprehensive analyses of genome-wide methylation and RNA epigenetics identify prognostic biomarkers, regulating the tumor immune microenvironment in lung adenocarcinoma.
Liu T; Yu S; Hu T; Ji W; Cheng X; Lv L; Shi Z
Pathol Res Pract; 2023 Aug; 248():154621. PubMed ID: 37336075
[TBL] [Abstract][Full Text] [Related]
10.
Zhang W; Li T; Hu B; Li H
Technol Cancer Res Treat; 2020; 19():1533033820957030. PubMed ID: 33084541
[TBL] [Abstract][Full Text] [Related]
11. Protein phosphatase 1 regulatory subunit 3G (PPP1R3G) correlates with poor prognosis and immune infiltration in lung adenocarcinoma.
Zhuo X; Chen L; Lai Z; Liu J; Li S; Hu A; Lin Y
Bioengineered; 2021 Dec; 12(1):8336-8346. PubMed ID: 34592886
[TBL] [Abstract][Full Text] [Related]
12. Advanced Glycation End Products' Receptor DNA Methylation Associated with Immune Infiltration and Prognosis of Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Yang J; Lin M; Zhang M; Wang Z; Lin H; Yu Y; Zheng Q; Chen X; Wu Y; Yao Q; Li J
Genet Res (Camb); 2023; 2023():7129325. PubMed ID: 37497166
[TBL] [Abstract][Full Text] [Related]
13. GALNT2/14 overexpression correlate with prognosis and methylation: potential therapeutic targets for lung adenocarcinoma.
Yu Y; Wang Z; Zheng Q; Li J
Gene; 2021 Jul; 790():145689. PubMed ID: 33964375
[TBL] [Abstract][Full Text] [Related]
14. LINC00467 Is Upregulated by DNA Copy Number Amplification and Hypomethylation and Shows ceRNA Potential in Lung Adenocarcinoma.
Wang W; Bo H; Liang Y; Li G
Front Endocrinol (Lausanne); 2021; 12():802463. PubMed ID: 35095769
[TBL] [Abstract][Full Text] [Related]
15. Integrative analysis confirms TPX2 as a novel biomarker for clinical implication, tumor microenvironment, and immunotherapy response across human solid tumors.
Zhu M; Wang X; Zhang Q; Xie C; Wang T; Shen K; Zhang L; Zhou X
Aging (Albany NY); 2024 Feb; 16(3):2563-2590. PubMed ID: 38315450
[TBL] [Abstract][Full Text] [Related]
16. High-resolution transcriptomics analysis of CXCL13
Zeng L; Chen X; Cui J; Zhang L; Li L; Yin C; Chen X; Sun J
J Thorac Dis; 2024 Jan; 16(1):201-214. PubMed ID: 38410612
[TBL] [Abstract][Full Text] [Related]
17. The High Expression of PTPRH Is Associated with Poor Prognosis of Human Lung Adenocarcinoma.
Chen A; Ding S; Shen X; Lin X
Comput Math Methods Med; 2021; 2021():9932088. PubMed ID: 34367321
[TBL] [Abstract][Full Text] [Related]
18. Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment.
Zhou H; Zheng M; Shi M; Wang J; Huang Z; Zhang H; Zhou Y; Shi J
BMC Cancer; 2021 Aug; 21(1):938. PubMed ID: 34416861
[TBL] [Abstract][Full Text] [Related]
19. [Comprehensive Analysis of the Relationship between m6A Methylation Patterns and Immune Microenvironment in Lung Adenocarcinoma].
Ke J; Cui J; Yang X; Du X; Ma B; Yu L
Zhongguo Fei Ai Za Zhi; 2022 May; 25(5):311-322. PubMed ID: 35599007
[TBL] [Abstract][Full Text] [Related]
20. Molecular Characterization and Prognosis of Lactate-Related Genes in Lung Adenocarcinoma.
Guo Z; Hu L; Wang Q; Wang Y; Liu XP; Chen C; Li S; Hu W
Curr Oncol; 2023 Feb; 30(3):2845-2861. PubMed ID: 36975430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
